Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 17 May 2024 for MAAT PHARMA, €20k. Read the official filing
Filing timeline
BuySaleSian Crouzet
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
50%
Median T+90
+4.2%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -39.2%Entry €8.14 · Close at T+365 €4.95
- +14.7%Entry €7.20 · Close at T+365 €8.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sian Crouzet: trading record in brief
Sian Crouzet is a declared insider of Maat Pharma (senior executive), with filings sourced from AMF. The record holds 2 filings, for trades running from 22 December 2023 to 15 May 2024.
Every open-market trade on record is a purchase: 2 purchases worth €35k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2024: 2 purchases and no sales on the market.
The latest filing, published on 17 May 2024, reports an open-market purchase of €20k in Maat Pharma. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Companies and markets linked to Sian Crouzet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,500 shares@ €8.0057.2% of flowActionEuronext ParisISIN FR00126348222024DD966261
Canonical exit: 13 Aug 2024 (T+90)
2,940 shares@ €5.1042.8% of flowActionEuronext ParisISIN FR00126348222024DD946715
Canonical exit: 21 Mar 2024 (T+90)
2 of 2 declarations
